Kannalife Sciences, Inc. (“Kannalife”), is a pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. Kannalife Sciences currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the Commercialization of U.S. Patent #6630507, “Cannabinoids as Antioxidants and Neuroprotectants” (the “‘507 Patent”). Further, Kannalife has developed its own patented molecules lead by KLS-13019 called by TIME Magazine/SI as a “super-CBD” and was recently awarded U.S. Patent #9611213, “Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy et al.”. Kannalife is currently conducting research and development at the Bucks County Pennsylvania Biotechnology Center in Doylestown, PA, to treat Hepatic Encephalopathy (“HE”), Chronic Traumatic Encephalopathy (“CTE”) and Chemotherapy Induced Peripheral Neuropathy ("CIPN").
View Top Employees from Kannalife Sciences, Inc.Website | http://www.neuropathix.com |
Revenue | $24 million |
Employees | 7 (1 on RocketReach) |
Founded | 2010 |
Address | 3805 Old Easton Road, Doylestown, Pennsylvania 18901, US |
Phone | (858) 883-2642 |
Industry | Biotechnology, Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare, Science and Engineering, Drug Discovery, Drug Manufacturing & Research, Health Care, Pharmaceutical |
Web Rank | 26 Million |
Keywords | Kannalife, Dr Omalu Bennet Cannabis, Nick Lowery Kannalife |
Competitors | Altravax, Inc., Biokine Therapeutics Ltd., Boston Therapeutics, Inc. (OTCQB:BTHE), Ischemix, Principia Biopharma |
SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Kannalife Sciences, Inc. employee's phone or email?
The Kannalife Sciences, Inc. annual revenue was $24 million in 2024.
Dean Petkanas is the CEO of Kannalife Sciences, Inc..
1 people are employed at Kannalife Sciences, Inc..
Kannalife Sciences, Inc. is based in Doylestown, Pennsylvania.
The NAICS codes for Kannalife Sciences, Inc. are [3254, 32541, 541, 54, 32, 325].
The SIC codes for Kannalife Sciences, Inc. are [28, 2834, 283].